Sickle cell anemia is caused by a single genetic mutation in the gene that produces hemoglobin, the protein in red blood cells that carries oxygen throughout your body. Specifically, one DNA letter is swapped (A to T) in the sixth position of the beta-globin gene, which changes one amino acid from glutamic acid to valine. That tiny change is enough to alter the shape and behavior of red blood cells, triggering a cascade of problems throughout the body.
About 7.74 million people worldwide live with sickle cell disease, with roughly 515,000 new cases born each year. Nearly 80% of those cases occur in sub-Saharan Africa. In the United States, every state screens newborns for the condition at birth.
The Genetic Mutation Behind It
Hemoglobin is built from protein chains, and the beta-globin gene provides the instructions for one of them. In sickle cell anemia, the single-letter DNA swap produces an altered form of hemoglobin called hemoglobin S (HbS). Normal hemoglobin (hemoglobin A) has a glutamic acid at that position, which carries an electrical charge and interacts well with water. Valine, its replacement in HbS, is water-repelling. That one chemical difference creates a sticky patch on the surface of the hemoglobin molecule, and that sticky patch is responsible for everything that follows.
Sickle cell anemia is what geneticists call a monogenic disease: it stems from a defect in just one gene. Despite that simplicity, the downstream effects are wide-ranging and severe.
How Sickle Hemoglobin Damages Red Blood Cells
When red blood cells deliver oxygen to tissues, the hemoglobin inside them releases that oxygen and shifts into a deoxygenated state. In normal red blood cells, this is uneventful. But in cells carrying hemoglobin S, the sticky patches on deoxygenated HbS molecules lock together, forming long, rigid fibers inside the cell. These fibers force the normally round, flexible red blood cell into a crescent or “sickle” shape.
This process, called polymerization, happens in two stages. The first fibers form slowly, like a reaction that needs to build momentum. But once a few fibers exist, new ones rapidly branch off their surfaces, and the polymer growth becomes exponential. This creates what looks like a delay followed by a sudden burst of sickling, which is why symptoms can seem to come on quickly after a trigger like physical exertion, cold temperatures, or dehydration reduces oxygen levels in the blood.
When the cell picks up oxygen again in the lungs, the fibers can dissolve and the cell may return to its normal shape. But repeated cycles of sickling and unsickling damage the cell membrane. Over time, some cells become permanently rigid and misshapen. A healthy red blood cell lives about 120 days. Sickled red blood cells survive roughly 10 to 20 days, and studies of related sickle cell conditions show average red cell lifespans around 29 days. Your body can’t replace them fast enough, which is why chronic anemia is a hallmark of the disease.
How Blocked Blood Vessels Cause Pain
The rigid, sickle-shaped cells don’t flow smoothly through blood vessels. But the process that leads to a pain crisis is more complex than simple clogging. Research points to a two-step model of how blockages form.
First, younger and more flexible sickle cells stick to the walls of small blood vessels, particularly in the tiny veins just past the capillaries. This adhesion slows blood flow in those vessels. As transit time increases, oxygen levels drop locally, which triggers more sickling among the denser, more rigid red blood cells passing through. Those stiff cells then get physically trapped behind the ones already stuck to the vessel wall. White blood cells pile on as well, narrowing the passage further. The result is a vaso-occlusive crisis: a blockage that starves nearby tissue of oxygen and causes intense pain, most commonly in the chest, abdomen, joints, and bones.
The stuck sickle cells also damage the vessel lining itself, triggering oxidative stress and inflammation. The inflamed vessel walls become even stickier, expressing more adhesion molecules on their surface, which makes future blockages more likely. This creates a cycle where each crisis primes the body for the next one.
How Sickle Cell Anemia Is Inherited
Sickle cell anemia follows an autosomal recessive inheritance pattern. You have two copies of the beta-globin gene, one from each parent. To develop sickle cell disease, you need to inherit the HbS mutation from both parents. If you inherit it from only one parent, you have sickle cell trait, meaning you carry one normal gene and one sickle gene.
When both parents carry sickle cell trait, each pregnancy has these odds:
- 25% chance the child inherits two normal genes and is unaffected
- 50% chance the child inherits one normal gene and one sickle gene (sickle cell trait, a carrier)
- 25% chance the child inherits two sickle genes and has sickle cell disease
These probabilities apply independently to each pregnancy. Having one child with sickle cell disease doesn’t change the odds for the next child. People with sickle cell trait typically have about 35 to 40% hemoglobin S in their blood, which is generally not enough to cause symptoms under normal conditions.
Why the Sickle Cell Gene Persists
Given how damaging sickle cell disease is, it might seem surprising that the gene remains so common, particularly in tropical regions. The reason is that carrying just one copy of the sickle gene provides significant protection against malaria, one of the deadliest infectious diseases in human history.
The malaria parasite invades red blood cells to reproduce. In people with sickle cell trait, the parasite has a harder time growing and multiplying inside HbAS red blood cells. Infected cells also tend to sickle, which flags them for destruction by the spleen before the parasite can complete its life cycle. Beyond these physical defenses, research published in PLoS Medicine found that carrying the trait also enhances the immune system’s ability to recognize and attack malaria-infected cells, accelerating the development of malaria-specific immunity.
This means that in regions where malaria is common, people who carry one copy of the sickle gene have a survival advantage over those with two normal copies. Natural selection maintains the gene in the population even though inheriting two copies causes serious disease. This is why sickle cell disease is most prevalent in sub-Saharan Africa, the Mediterranean, the Middle East, and India, all areas with historically high rates of malaria.
Common Triggers for Symptoms
Because sickling is driven by low oxygen levels in the blood, anything that reduces oxygen delivery or increases the body’s oxygen demand can trigger a crisis. Common triggers include dehydration (which thickens the blood and slows circulation), infections or fevers, sudden temperature changes, high altitude, intense physical exertion, and emotional stress. Some crises have no identifiable trigger at all.
The severity and frequency of symptoms vary widely from person to person, even among people with the same genetic profile. Some people experience pain crises several times a year, while others go long stretches between episodes. This variability is partly influenced by other genetic factors, including how much fetal hemoglobin (a form of hemoglobin normally produced before birth) a person continues to make. Fetal hemoglobin doesn’t polymerize with hemoglobin S, so higher levels of it dilute the sickle hemoglobin and reduce sickling.
Long-Term Effects on the Body
The combination of chronic anemia and repeated blood vessel blockages takes a toll on virtually every organ system over time. The spleen, which filters damaged red blood cells, often becomes overwhelmed and stops functioning properly in early childhood, leaving people more vulnerable to certain bacterial infections. The kidneys, lungs, eyes, and brain are all susceptible to damage from blocked blood flow.
Stroke is a particularly serious risk, especially in children. Repeated blockages in the small vessels of the lungs can lead to a condition called acute chest syndrome, which resembles pneumonia and is one of the leading causes of hospitalization. Bones can develop areas of dead tissue where blood supply was cut off, and the chronic breakdown of red blood cells releases excess iron and bilirubin, which can lead to gallstones and liver complications.
All of these complications trace back to the same root cause: a single amino acid change in one protein, repeated billions of times across trillions of red blood cells, altering their shape just enough to disrupt the entire circulatory system.